Amniotic Tissue & Regenerative Wound Matrix — Multi-State

Established regenerative medicine company expanding independent distribution for a proven amniotic membrane allograft line used in chronic wound, DFU, and surgical wound closure applications. Medicare and commercial payer coverage in place. Average ticket $1,200–$3,500 per case. Company provides dedicated clinical specialist support and reimbursement coding assistance. Target call points include wound care clinics, podiatry practices, and outpatient surgery centers. Seeking motivated reps with existing wound care or podiatry access.